[125I]PD151242 [7736]
[125I]PD151242
| SMILES | CC(C)C[C@H](NC(=O)N1CCCCCC1)C(=O)N[C@H](Cc1cn(C)c2ccccc12)C(=O)N[C@H](Cc1ccc(O)cc1)C(=O)O |
| InChIKey | JVILFANCFWZBFU-ZGIBFIJWSA-N |
| Sequence | LWY |
| HELM | PEPTIDE1{[*C(=O)[C@H](CC(C)C)NC(=O)N1CCCCCC1 |$_R2;;;;;;;;;;;;;;;;;$|].[*C(=O)[C@@H](Cc1cn(c2c1cccc2)C)N* |$_R2;;;;;;;;;;;;;;;;_R1$|].[dY]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 6 |
| Hydrogen bond donors | 5 |
| Rotatable bonds | 12 |
| Log P | 3.724 |
| Molecular weight (Da) | 619.3 |
| Stereochemistry info | unspecified |
| Radioactive | 125I |
Database connections
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
[125I]PD151242
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0